Literature DB >> 3371142

Bile acid sequestration by the solid phase of stools in cystic fibrosis patients. Role of pancreatic enzymes.

A Jonas1, A Diver-Haber.   

Abstract

The distribution of bile acids in the stool of seven cystic fibrosis (CF) patients with severe or mild steatorrhea was examined and compared with that of three controls. Results indicated significantly lower endogenous bile acid concentrations in the stool water phase, obtained by centrifugation, in the CF patients (12.0 +/- 3.5%), compared with the controls (25.5 +/- 8.1%). In vitro incorporation of labeled cholic acid (CA) and deoxycholic acid (DCA) demonstrated a stronger binding of both to the particulate matter of stools in the CF group. Using equilibrium dialysis, the calculated concentrations of unbound CA and DCA in the CF group measured 0.78 and 0.3 mumol/g homogenate, respectively, and in the control patients 1.76 and 1.39 mumol/g homogenate, respectively. Partial release of bile acids from CF stool pellets was achieved by the addition of trypsin and elastase, as well as by alkalinization. It is suggested that in patients with CF, stool bile acids are bound to the undigested protein fraction, which makes them unavailable for colonic resorption.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371142     DOI: 10.1007/bf01540437

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Protection by dietary proteins against the effects of bile acids on rat jejunum and stomach.

Authors:  J F Kruidenier; H V Ammon; U K Charaf; L G Walter
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

2.  Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.

Authors:  A F Hofmann; J R Poley
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

3.  Test strip meconium screening for cystic fibrosis.

Authors:  W T Bruns; T R Connell; J A Lacey; K E Whisler
Journal:  Am J Dis Child       Date:  1977-01

4.  Effects of dietary nutrients on intestinal taurocholic acid absorption.

Authors:  J D Fondacaro; R H Wolcott
Journal:  Proc Soc Exp Biol Med       Date:  1981-11

5.  Factors in the mechanism of diarrhea in bile acid malabsorption: fecal pH--a key determinant.

Authors:  B McJunkin; H Fromm; R P Sarva; P Amin
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

6.  The fecal microflora and bile acids in children with cystic fibrosis.

Authors:  C C Roy; G Delage; A Fontaine; L Robitaille; L Chartrand; A Weber; C L Morin
Journal:  Am J Clin Nutr       Date:  1979-12       Impact factor: 7.045

7.  Colonic absorption of unconjugated bile acids: perfusion studies in man.

Authors:  H S Mekhjian; S F Phillips; A F Hofmann
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

8.  Stool output and composition in the chronic non-specific diarrhoea syndrome.

Authors:  A Jonas; A Diver-Haber
Journal:  Arch Dis Child       Date:  1982-01       Impact factor: 3.791

9.  Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency.

Authors:  C Colombo; A Roda; E Roda; L Piceni Sereni; A Brega; R Fugazza; A Giunta
Journal:  J Pediatr Gastroenterol Nutr       Date:  1984-09       Impact factor: 2.839

10.  Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis.

Authors:  P L Zentler-Munro; D R Fine; J C Batten; T C Northfield
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

View more
  2 in total

Review 1.  Enzyme contents of pancreatic extract preparations. Are they optimal?

Authors:  S Maguire; M C Goodchild
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

2.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.